Recently, elevated levels of cytotoxic CD8+ T cells in the TME have been linked with positive anti-tumor effects in various cancers, indicating a good prognosis in patients with elevated cytotoxic CD8+ TILs (30–32). The gene discussed is CD8A; the disease is neoplasm.